Founder of Dalya Partners, Chris has served more than 20 years as a management consultant, assisting various companies in the life science industry in achieving critical objectives and developing strategic solutions to meet a wide range of client needs. Chris has led executive-level consulting teams for major vaccine pharmaceutical companies and emerging biotechnology companies, with focus on research and development, operations, government programs and public health.
Having been engaged to lead multiple pandemic and public health initiatives during the COVID and H1N1 pandemics, Chris now leads Dalya Partners’ effort to address the mental health crisis that has impacted youth and families worldwide. Chris uses pandemic thinking and experience to accelerate new treatments, drive major initiatives and lead technology, health systems and community approaches that keep people healthy. As a Rotarian, Chris is driving the “Help Kids Now” Initiative to help address the youth mental health crisis, leading efforts for family-centric approaches to assist at the local level.
Prior to forming Dalya Partners, Chris was a founding partner of Valeo Group Consulting, and a Manager Consultant at Pittiglio, Rabin, Todd, and McGrath (PRTM), a highly successful consulting firm focused on healthcare and life sciences. While at PRTM, Chris supported Fortune 100 pharmaceutical and Biotechnology clients, developing business strategy, operational improvement, technology transfer and business process improvement.
Chris has significant R&D experience in genomic technologies and immunology, having worked as a scientist at the Joint Genome Institute based in California where he performed genomics based research and sequencing to support the Human Genome Project. He received his Ph.D. in Medical Sciences from the University of Florida, an MBA from Cornell University and a B.S. in Molecular Biology from Lehigh University.